During a routine check-up, a patient reports muscle rigidity following initiation of antipsychotic therapy. What does this indicate?

Choice A reason: Acute dystonia involves sudden, involuntary muscle contractions often resulting in abnormal posturing, such as torticollis or oculogyric crisis. While it involves muscle tension, it is typically more spasmodic and localized than the generalized rigidity and slowed movements that characterize the parkinsonian-like side effects seen during routine therapy check-ups. Choice B reason: Pseudoparkinsonism is induced by the blockade of dopamine D2 receptors in the nigrostriatal pathway, mimicking the symptoms of Parkinson's disease. This manifests as generalized muscle rigidity, a shuffling gait, tremors, and bradykinesia. It is a common subacute reaction that develops within days to weeks of starting an antipsychotic. Choice C reason: Tardive dyskinesia is characterized by hyperkinetic movements rather than rigidity. It usually develops after months or years of neuroleptic use. The pathophysiology involves dopamine receptor supersensitivity, leading to uncontrollable movements like lip smacking, which is the functional opposite of the stiff, rigid muscles described in this specific clinical scenario. Choice D reason: Akathisia presents as a profound sense of restlessness and an inability to sit still. Patients often describe feeling like they are "jumping out of their skin." This condition is characterized by excessive motor activity and subjective agitation rather than the physical stiffness or rigidity found in pseudoparkinsonism.